Tim J. Gabel is RTI International’s president and chief executive officer, overseeing an institute with annual revenues of approximately $1.3 billion and 6,000 worldwide staff members supporting projects in more than 93 countries. Mr. Gabel became CEO in 2022, having served the previous 10 years as executive vice president of Social, Statistical, and Environmental Sciences, the largest business unit within RTI. A long-tenured RTI employee, Mr. Gabel has served at every level of RTI leadership, guiding various divisions and operating units to grow by maintaining a focus on operational excellence, client centricity, and innovation.

Mr. Gabel is a member of the American Statistical Association, American Association for Public Opinion Research, and American Public Health Association. He has adjunct academic appointments at the University of Wyoming and the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. Over the course of his career Mr. Gabel has contributed to books, articles and technical reports on a variety of research topics, including most recently co-editing the book The Essential Role of Language in Survey Research, published in 2020 by RTI Press. Mr. Gabel serves his community in a variety of volunteer roles, including board member for Research Triangle Foundation of North Carolina, Tocqueville Society member of the United Way of Alamance County, and member of the Board of Visitors for the University of Wyoming College of Arts & Sciences.

Patrick Jordan is a seasoned leader in the life sciences industry with over 25 years of experience as a biopharma CEO, private equity managing partner, and global CRO executive. Throughout his career, Patrick has led stellar teams to multiple product approvals, driven investments in late-stage drugs, and spearheaded international partnerships while focusing on improving patient outcomes.

His passion for healthcare shines through his ability to build high-performing teams that deliver exceptional results to investors, stakeholders, and, most importantly, patients. Patrick has consistently created solutions to overcome bottlenecks in drug development, including innovations in patient recruitment and optimizing clinical research through the world’s largest integrated patient data database. As a CEO, he is proud to have led a team that developed and launched the first FDA-approved therapy for a condition affecting millions of women. As a private equity leader, he and his partners have managed over $2 billion in investments, shaping the future of biopharma.

Doug Harward is an entrepreneur and a recognized leader in training and outsourcing business models. As one of the industry's top strategists and analysts, Doug is widely regarded as an authority on competitive analysis in training services. His expertise includes working with multinational corporations and new business start-ups to build effective and impactful training organizations.

Doug is also the co-author of What Makes a Great Training Organization?, a book that outlines critical insights and strategies for developing high-performing training programs. His thought leadership has earned him a prominent reputation in the industry, and he helps businesses optimize their training services to achieve success.